These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 15333195)
21. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755 [TBL] [Abstract][Full Text] [Related]
22. Delay in seeking treatment and adherence to tuberculosis medications in Russia: a survey of patients from two clinics. Woith WM; Larson JL Int J Nurs Stud; 2008 Aug; 45(8):1163-74. PubMed ID: 17854809 [TBL] [Abstract][Full Text] [Related]
24. Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection. Eidlitz-Markus T; Zeharia A; Baum G; Mimouni M; Amir J Chest; 2003 Mar; 123(3):736-9. PubMed ID: 12628871 [TBL] [Abstract][Full Text] [Related]
25. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Balbay O; Annakkaya AN; Arbak P; Bilgin C; Erbas M Jpn J Infect Dis; 2005 Jun; 58(3):152-8. PubMed ID: 15973006 [TBL] [Abstract][Full Text] [Related]
26. In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection. Menzies D; Dion MJ; Francis D; Parisien I; Rocher I; Mannix S; Schwartzman K Int J Tuberc Lung Dis; 2005 Dec; 9(12):1343-8. PubMed ID: 16466056 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection. Holland DP; Hamilton CD; Weintrob AC; Engemann JJ; Fortenberry ER; Peloquin CA; Stout JE Pharmacotherapy; 2009 May; 29(5):503-10. PubMed ID: 19397460 [TBL] [Abstract][Full Text] [Related]
28. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
29. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Garvie PA; Lensing S; Rai SN Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298 [TBL] [Abstract][Full Text] [Related]
31. [Miss-management in treatment failure of pulmonary tuberculosis]. Ito K; Yoshiyama T; Wada M; Ogata H Kekkaku; 2004 Oct; 79(10):561-7. PubMed ID: 15631107 [TBL] [Abstract][Full Text] [Related]
32. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]. Yoshiyama T; Ogata H; Ito K; Aono A; Wada M Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318 [TBL] [Abstract][Full Text] [Related]
33. Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. Andersson K; Melander A; Svensson C; Lind O; Nilsson JL Eur J Public Health; 2005 Dec; 15(6):621-6. PubMed ID: 16126746 [TBL] [Abstract][Full Text] [Related]
34. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system]. Isakova ZhT Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033 [TBL] [Abstract][Full Text] [Related]
35. Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS. Mishra P; Hansen EH; Sabroe S; Kafle KK Patient Educ Couns; 2006 Oct; 63(1-2):29-37. PubMed ID: 16242297 [TBL] [Abstract][Full Text] [Related]
36. New approaches to the treatment of latent tuberculosis. Sterling TR Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686 [TBL] [Abstract][Full Text] [Related]
37. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Uzochukwu BS; Onwujekwe OE; Onoka AC; Okoli C; Uguru NP; Chukwuogo OI Health Policy Plan; 2009 May; 24(3):189-96. PubMed ID: 19276155 [TBL] [Abstract][Full Text] [Related]
38. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536 [TBL] [Abstract][Full Text] [Related]
39. Adherence to drug treatment in association with how the patient perceives care and information on drugs. Ulfvarson J; Bardage C; Wredling RA; von Bahr C; Adami J J Clin Nurs; 2007 Jan; 16(1):141-8. PubMed ID: 17181676 [TBL] [Abstract][Full Text] [Related]
40. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Umubyeyi AN; Vandebriel G; Gasana M; Basinga P; Zawadi JP; Gatabazi J; Pauwels P; Nzabintwali F; Nyiramasarabwe L; Fissette K; Rigouts L; Struelens MJ; Portaels F Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]